References
Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, Drake C, O’Dea P, Bermingham N, Keohane C, Grossman SA, Moylan EJ, O’Reilly S (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol 114(1):149–154
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2013.03.010
Lechner MG et al (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 185:2273–2278
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alexiou, G.A., Vartholomatos, E. & Voulgaris, S. Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma. J Neurooncol 115, 521–522 (2013). https://doi.org/10.1007/s11060-013-1240-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-013-1240-1